JCVI deputy chair says they're faced with a "difficult problem" considering whether to recommend under 40s get an alternative jab to AZ.

Prof Harnden says if that happens, it will "delay the immunisation programme" and may lead to "many more deaths and hospitalisations".

— Aubrey Allegretti (@breeallegretti) April 28, 2021